Actively Recruiting
"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.
Led by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · Updated on 2026-01-05
244
Participants Needed
3
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the "Active Delta Referral" Project is to estimate the prevalence of anti-HDV positivity among HBsAg-positive patients hospitalized in the Department of Medicine at ASST Papa Giovanni XXIII in Bergamo, as well as among patients at the SerD and the Prison Healthcare Unit of the same ASST, following the introduction of the new methodology in 2025, and to compare these findings with existing estimates for outpatients.
CONDITIONS
Official Title
"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged �3e=18 years
- Hospitalized at the Department of Medicine of ASST Papa Giovanni XXIII in Bergamo, or attending the SerD or the Penitentiary Health Service of Bergamo
- HBsAg positivity
- Obtaining informed consent
You will not qualify if you...
- Lack of informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
ASST PAPA GIOVANNI XXIII - Medicine Dept.
Bergamo, Italy
Actively Recruiting
2
ASST Papa Giovanni XXIII - SerD
Bergamo, Italy
Actively Recruiting
3
ASST Papa Giovanni XXIII - SS Sanità Penitenziaria
Bergamo, Italy
Actively Recruiting
Research Team
E
Eleonora Sfreddo
CONTACT
F
FRANCESCA FENILI
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here